1,011
Participants
Start Date
January 31, 2012
Primary Completion Date
February 28, 2014
Study Completion Date
February 28, 2014
ONCOTYPEDX Test
Gene signature test containing 21 genes (16 cancer-related genes, e.g., invasion, proliferation, ER, Her 2 and five reference genes) and generates an individualized recurrence score.
Simcoe Muskoka Cancer Program - Royal Victoria Hospital, Barrie
Quinte Healthcare Corporation, Belleville
William Osler Health Centre, Brampton
Brantford General Hospital, Brantford
Joseph Brant Hospital, Burlington
Cambridge Memorial Hospital, Cambridge
Northeast Cancer Centre of Health Sciences North - Horizon Sante-Nord, Greater Sudbury
Juravinski Cancer Centre, Hamilton
Cancer Centre of Southeastern Ontario at Kingston, Kingston
Grand River Regional Cancer Centre, Kitchener
London Regional Cancer Centre, London
Markham Stouffville Hospital, Markham
The Credit Valley Hospital, Mississauga
Stronach Regional Cancer Centre, Newmarket
R.S. McLaughlin Durham Regional Cancer Centre - Lakeridge Health, Oshawa
The Ottawa Hospital Regional Cancer Centre, Ottawa
Grey Bruce Health Services, Owen Sound
Peterborough Regional Health Centre, Peterborough
Mackenzie Health, Richmond Hill
Bluewater Health, Sarnia
Algoma District Cancer Program - Sault Area Hospital, Sault Ste. Marie
Rouge Valley Health System, Scarborough Village
The Scarborough Hospital, Scarborough Village
Niagara Health System, St. Catharines
Thunder Bay Regional Health Sciences Centre, Thunder Bay
North York General Hospital, Toronto
Toronto East General Hospital, Toronto
Sunnybrook Health Sciences - Odette Cancer Centre, Toronto
St. Michael's Hospital, Toronto
Mount Sinai Hospital, Toronto
Princess Margaret Hospital, Toronto
St. Joseph's Healthcare, Toronto
Trillium Health Centre, Toronto
Humber River Regional Cancer Centre, Toronto
Windsor Regional Cancer Centre, Windsor
Ontario Ministry of Health and Long Term Care
OTHER_GOV
Ontario Clinical Oncology Group (OCOG)
OTHER